NTN BUZZTIME

Company

Ernexa Therapeutics Inc.

Filed

July 9, 2018

Accession Number

0001105907-18-000016

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →